- Bernard Fortier, CEO, Tetra Bio-Pharma Inc. (TBP), joined Tim Babcock, Director, Listed Issuer Services, TSX Venture Exchange, to open the market
Tags: #smallcapstocks, $TSXV, CSE
TORONTO, Dec. 5, 2017 – Bernard Fortier, CEO, Tetra Bio-Pharma Inc. (TBP), joined Tim Babcock, Director, Listed Issuer Services, TSX Venture Exchange, to open the market. Tetra Bio-Pharma biopharmaceutical company that is engaged in the development of Bio Pharmaceuticals and Natural Health Products containing Cannabis and other medicinal plant based elements. Tetra Bio-Pharma Inc. commenced trading on TSX Venture Exchange on August 16, 2017.
SOURCE TMX Group Limited
Tags: #smallcapstocks, $TSXV, CSE
Comments are closed.
AGORACOM Small-cap Investor Relations Blog is proudly powered by
WordPress
Entries (RSS)
and Comments (RSS).